TUYET VU: Open Payments
NPI 1740521723 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 8 payments from 6 companies in 2025. Trend: 2023 $112 · 2024 $295 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 1 | $116 |
| Amgen Inc. | 3 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
Products named: VOXZOGO 1.2mg, TZIELD, OTEZLA, REZDIFFRA, Cologuard Collection Kit, Rybelsus, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
